Latest News

09.23.19

GenSight Biologics Reports Sustained Efficacy and Safety at 96 Weeks in RESCUE Phase 3 Trial of GS010 for the Treatment of LHON

Source: GenSight Biologics

09.23.19

Novo Nordisk’s Rybelsus Gains FDA Approval as First Oral GLP-1 Receptor Agonist for Type 2 Diabetes

Source: FirstWord

09.20.19

Boehringer Ingelheim Partners with Inflammasome Therapeutics to Develop Novel Therapies for Patients with Retinal Diseases

Source: Boehringer Ingelheim

09.20.19

US House Speaker Nancy Pelosi Introduces Plan to Permit Price Negotiation for Some Drugs

Source: FirstWord

09.20.19

Konan Medical’s EyeKinetix Pupillograph is Now Available in the United States

Source: Konan Medical

09.19.19

Eye Cancer Researchers at Bascom Palmer and Sylvester Identify Function of Key Tumor Suppressor

Source: Bascom Palmer Eye Institute

09.19.19

Schwind Introduces Schwind ATOS Femtosecond Laser With SmartSight

Source: Schwind

09.19.19

Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to DME or RVO

Source: Graybug Vision

09.18.19

Vertical Pharmaceuticals Announces Submission of New Drug Application for RVL-1201

Source: Vertical Pharmaceuticals

09.18.19

RightEye Releases Fully Commercialized Version of EyeQ Trainer Oculomotor Exercise Program

Source: RightEye

View more stories